Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Harvard Bioscience (NQ: HBIO ) 2.880 -0.050 (-1.71%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Harvard Bioscience < Previous 1 2 Next > HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024 August 08, 2024 HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024. Via InvestorPlace Holley And 2 Other Stocks Under $5 Insiders Are Buying June 17, 2024 Via Benzinga FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying June 10, 2024 Via Benzinga HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024 May 07, 2024 HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023 March 07, 2024 HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. Via InvestorPlace Earnings Preview For Harvard Bioscience November 06, 2023 Via Benzinga Preview: Harvard Bioscience's Earnings August 07, 2023 Via Benzinga Why Harvard Bioscience Stock Rose This Week April 27, 2023 The company reported improved revenue in Q1. Via The Motley Fool Harvard Bioscience's Return On Capital Employed Overview March 14, 2023 Via Benzinga Earnings Preview: Harvard Bioscience March 08, 2023 Via Benzinga Earnings Scheduled For March 7, 2024 March 07, 2024 Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. Via Benzinga A Preview Of Harvard Bioscience's Earnings March 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session August 30, 2023 Via Benzinga Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter April 17, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying March 16, 2023 The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga 10 Stocks Under $10 for 2023 January 03, 2023 In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10. Via InvestorPlace Earnings Preview: Harvard Bioscience November 07, 2022 Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Harvard... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session August 22, 2022 Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million. Via Benzinga $92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying August 19, 2022 U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades. Via Benzinga Stocks That Hit 52-Week Lows On Friday August 12, 2022 On Friday, 39 companies reached new 52-week lows. Via Benzinga Looking Into Harvard Bioscience's Return On Capital Employed May 19, 2022 Harvard Bioscience (NASDAQ:HBIO) brought in sales totaling $28.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 815.92%, resulting in a loss of $6.88... Via Benzinga 81 Biggest Movers From Yesterday May 05, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session May 04, 2022 Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... Via Benzinga Recap: Harvard Bioscience Q1 Earnings May 04, 2022 Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout March 08, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative... Via Benzinga Harvard Bioscience: Q4 Earnings Insights March 08, 2022 Harvard Bioscience (NASDAQ:HBIO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... Via Benzinga Earnings Scheduled For March 8, 2022 March 08, 2022 Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •... Via Benzinga Earnings Preview: Harvard Bioscience March 07, 2022 Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts... Via Benzinga Earnings Outlook For Harvard Bioscience March 07, 2022 Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts... Via Benzinga The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg March 06, 2022 Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.